AKRE Akre Focus ETF

Expense Ratio
0.98%
Previous close
$52.92
Est. 12 months change
+40.93%
Projected Price
$74.58

Profitability Metrics

Return on Equity (ROE)
44.06%
Return on Assets (ROA)
10.28%
Return on Invested Capital (ROIC)
28.30%
Weighted Average Cost of Capital (WACC)
9.61%
ROIC - WACC
18.70%
Updated : 2026-04-03 16:48 ET

Valuation Metrics

P/E Ratio
17.88
Forward P/E
20.42
PEG Ratio
1.39
Debt Current Ratio
1.50

Growth & Cash Flow

Gross Margin
65.76%
Operating Margin
18.29%
FCF Margin
30.45%
TTM Revenue Growth
14.53%
Projected 12M EPS Growth
-12.46%

Price Change

Price % from 50 SMA
-5.82%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MA13.14%
TSX:CSU11.38%
BN8.91%
KKR8.11%
V7.84%
TSXV:TOI6.42%
ROP6.29%
MCO6.07%
CSGP5.42%
FICO5.02%

ETF Analysis

Fund Overview

Akre Focus ETF (AKRE) currently reports 17 stock positions (subject to change), placing it in the narrowly constructed range by holdings breadth. The top line-up is MA (13.14%), TSX:CSU (11.38%), BN (8.91%), with MA as the largest single weight at 13.14%. Together, the top three holdings account for 33.43%, which means the fund's near-term behavior will be closely tied to how its largest positions perform. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 28.30%, WACC is 9.61%, and the economic spread is 18.70%. On balance, returns on invested capital exceed the cost of funding by a comfortable margin, which over time compounds favorably for long-term holders. Supporting metrics show ROE at 44.06% and ROA at 10.28%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

From a pricing standpoint, the portfolio sits at trailing P/E of 17.88, forward P/E of 20.42, PEG of 1.39. The narrow spread between trailing and forward multiples implies earnings expectations are relatively stable — the portfolio is not being priced for an earnings inflection. Growth-adjusted valuation is compelling at this PEG level — the multiple appears reasonable given the expected earnings trajectory. A current ratio reading of 1.50 points to holdings that are managing short-term obligations without apparent stress. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 65.76%, operating margin at 18.29%, and free cash flow margin at 30.45%. The gross margin reading is exceptional — a reliable indicator of competitively advantaged businesses. Operating margins are in good shape, consistent with businesses that maintain reasonable earnings conversion after overhead. Free cash flow conversion is exceptional, indicating holdings that are self-funding and cash-generative well above average. Read together, these margin levels suggest a portfolio where earnings durability is present in parts but not consistent across the full holding set.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 14.53% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 41.34%, where consensus pricing assumptions suggest sizable appreciation potential. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Balancing the strengths against the areas of uncertainty, the weight of evidence favors an optimistic view with appropriate risk awareness.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.